Showing 731-740 of 6039 results for "".
Sunscreen Perceptions, Promotion, and Use: Dermatologists' Perspectives
https://practicaldermatology.com/topics/practice-management/sunscreen-perceptions-promotion-and-use-dermatologists-perspectives/20741/What do dermatologists really think about the benefits of sunscreen?Treatment of Basal Cell Carcinomas in Elderly Patients
https://practicaldermatology.com/topics/general-topics/treatment-of-basal-cell-carcinomas-in-elderly-patients/21748/BCCs are increasingly prevalent in older patients. While surgery remains the gold standard of treatment, existing and emerging therapies may enhance outcomes.Nonverbal Communication in the Patient Consultation
https://practicaldermatology.com/topics/practice-management/1109_07-php/22059/Recognition of the most common body language cues can help you understand what your patients may be thinking but not saying out loud.Making Melanoma Diagnosis and Treatment More Predictable
https://practicaldermatology.com/topics/skin-cancer-photoprotection/making-melanoma-diagnosis-and-treatment-more-predictable/37102/Melanoma can be a very humbling disease. Some of the most talented doctors have been challenged over the years when diagnosing and planning treatment for melanoma because of its variability.An Update on the Use of Minocycline for the Treatment of Acne
https://practicaldermatology.com/columns/clinical-focus-1/an-update-on-the-use-of-minocycline-for-the-treatment-of-acne/23201/Advances in formulation technology have led to the development of a stable topical minocycline that recently received FDA approval. Here’s what you should know.The Role of Oral Contraceptive Pills in the Acne Treatment Plan
https://practicaldermatology.com/topics/general-topics/the-role-of-oral-contraceptive-pills-in-the-acne-treatment-plan/20483/When OCPs are the right choice for patients.Hitting the Target in Atopic Dermatitis: Interdisciplinary Team Training for Leveraging IL-13 Inhibitors to Address the Burden of Disease
https://practicaldermatology.com/programs/cme/hitting-the-target-in-atopic-dermatitis-interdisciplinary-team-training-for-leveraging-il-13-inhibitors-to-address-the-burden-of-disease/54437/On-demand webcast on the role of interleukin (IL)-13 in atopic dermatitis pathophysiology and strategies for leveraging IL-13 inhibitors to address disease burden and improve patient outcomes.GLP-1 Receptor Agonists: Current Roles in Medicine
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-current-roles-in-medicine/48897/In recent years, the popularity of glucagon-like peptide 1 receptor agonists (GLP-1RAs) has skyrocketed, along with interest in clinical applications beyond diabetes and weight management. Here, we present a brief review of GLP-1RAs, including a history, a look at the mechanism of action, pivotal reMaximizing Valuation and Outcomes for Practice Owners: A Conversation with Dana Jacoby
https://practicaldermatology.com/topics/practice-management/maximizing-valuation-and-outcomes-for-practice-owners-a-conversation-with-dana-jacoby/29889/Contributor Clint Bundy recently interviewed Dana Jacoby, President and CEO of Vector Medical Group, an operational and strategic consulting firm focused on the healthcare sector, to discuss building value in a dermatology and aesthetics practice and optimal ways to achieve full value for that businCannabinoid Photo-Rejuvenation: A Clinico-Pathologic Study
https://practicaldermatology.com/topics/feature/cannabinoid-photo-rejuvenation-a-clinico-pathologic-study/29188/In this study, we sought to assess the effectiveness of a novel topical formulation containing CBD isolate, resveratrol, thyme extract, caffeine, and lecithin in reversing photodamage over a 90-day treatment period.